Get ready for the annual workplace health event, a feature of the university’s wellness program, which begins May 25 and takes participants on a virtual global journey.
When complete, the revamped website will better advance the university’s strategic communication goals and will be easily navigable across a variety of different devices.
IT has unveiled its inventory dashboard and support matrix, two resources it hopes will help streamline the way labs and departments manage their technology purchases, and better plan software updates.
The Tri-Institutional Therapeutics Discovery Institute is expanding its scope to support the development of antibody therapies, which are successfully used to treat a growing list of diseases.
Rankings released by the European Commission–funded U-Multirank survey place Rockefeller in the top spot in categories related to the impact of its research and the transfer of knowledge to the private sector. The results incorporate data from over 1,300 institutions in more than 90 countries.
Making complicated scientific concepts relevant and accessible to a broad audience is a difficult skill to master. Evolutionary biologist, educator, and author Sean B. Carroll was recently celebrated for his ability to inspire and educate others with Rockefeller’s 2016 Lewis Thomas Prize for Writing about Science.
PBS Newshour paid a visit to Leslie Vosshall’s laboratory to learn how mutant mosquitoes may help in the fight against Zika. Ali Brivanlou and Jesse Ausubel were also highlighted in the press.
Last month, many Rockefeller employees received emails embedded with malicious code in what turned out to be an unusually dangerous “ransomware” attack. Here’s what we should all be doing to keep our devices and our data safe from harm.
The university’s Board of Trustees elected three new members at their February 17 meeting: William A. Ackman, chief executive officer of Pershing Square Capital Management; Scott K.H. Bessent, chief executive officer of Key Square Group; and Evan G. Greenberg, chairman of Chubb Limited.
Dr. Marraffini is exploring an immune response used by bacteria to defend against viruses. His work is mainly focused on understanding the basic biology and evolution of microorganisms, but it also has implications for the development of gene-editing technologies.